Nasdaq · Biological Products, (No Diagnostic Substances)

Moderna, Inc. (MRNA)

Moderna's next earnings date, recent SEC filings, insider trades and reported financials, with end-of-day prices. Every number carries its date and source.

Track MRNA free Write a thesis on MRNA

Last close

$197.24

−0.80% 1 day+701.1% 52 weeks

As of Sep 28, 2026, end of day (IEX). Not a live quote.

MRNA · one year of daily closes

Sep 25, 2025 to Sep 28, 2026 · end of day · IEX

Closing prices, split-adjusted, from trades on the IEX exchange (published the next trading day). Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

1-day change: −0.80%; From $198.84 the session before
52-week change: +701.1%; Close vs close ~252 sessions earlier
52-week range: $22.36–$198.84; Lowest and highest closing prices
Market cap: $78.7B; Last close × shares outstanding (SEC)
Revenue (TTM): $2.2B; 12 months to Jun 30, 2026
Net income (TTM): −$3.2B; 12 months to Jun 30, 2026
Diluted EPS (TTM): −$7.98; 12 months to Jun 30, 2026

Financials: trailing twelve months from Moderna’s reported US-GAAP figures, SEC EDGAR XBRL company facts, period ended Jun 30, 2026.

Recent SEC filings

Source: SEC EDGAR. Each line is written from the form type and the official 8-K item titles; open the filing for the full text. All MRNA filings on EDGAR

Next earnings

~Nov 5, 2026Estimated

Past results were usually filed before the open

Estimated from past filing dates. Moderna hasn't announced this date; Vero projects it from the rhythm of its past SEC filings, so treat it as approximate.

Estimated from SEC EDGAR filing dates

Insider activity (last 90 days)

Open-market buys: 0; filings · 0 shares
Open-market sales: 5; filings · 671,464 shares

Source: SEC EDGAR Form 4, filed in the 90 days to Oct 1, 2026. Counts are filings with at least one open-market purchase (P) or sale (S); grants, option exercises, tax withholding and gifts are left out.

Insider share counts and prices are as reported on Form 4.

With a free Vero account

What Vero tracks about Moderna

Each new Moderna filing and headline, summarized in plain English and scored 1–10 for how much it matters. Write down why you own MRNA, and Vero reads every new item against those reasons: confirms, challenges or breaks. Alerts say when something crosses the line you set.

Track MRNA free Write a thesis on MRNA

The free plan follows 3 stocks, with no card and no end date.

Moderna (MRNA): questions, answered from the data

When is Moderna's next earnings date?

Around Nov 5, 2026 (past results were usually filed before the open), but that is an estimate, not a date Moderna has announced. Estimated from past filing dates: Vero projects it from the dates of Moderna's past SEC filings (source: Estimated from SEC EDGAR filing dates). Treat it as approximate until the company confirms it.

What was MRNA's last closing price?

MRNA closed at $197.24 on Sep 28, 2026. This is an end-of-day price from trades on the IEX exchange, published the next trading day, not a live quote, and it can differ slightly from the consolidated official close. That was −0.80% from the session before and +701.1% over 52 weeks.

Have Moderna insiders bought or sold shares recently?

In the 90 days to Oct 1, 2026, SEC Form 4 shows 0 filings with open-market purchases (0 shares) and 5 filings with open-market sales (671,464 shares). The most recent: Hoge Stephen (President) reported selling 80,575 shares, filed Sep 16, 2026. Grants, option exercises and tax withholding are not counted. Insider share counts and prices are as reported on Form 4.

What did Moderna file with the SEC most recently?

An 8-K filed on Sep 30, 2026: Current report: Executive or director change; Regulation FD disclosure. Before that, an 8-K on Sep 1, 2026 and a 10-Q on Jul 31, 2026. Each filing is linked to the original on SEC EDGAR.

Is this page a recommendation to buy or sell MRNA?

No. It reports public data (end-of-day prices from IEX and filings from SEC EDGAR) with the date of each. Vero is a research tool, not a financial adviser, and nothing here is a recommendation to buy or sell any security.

Closes are end of day (IEX), as of each page’s date. Grouped by SEC industry code (SIC).

Prices: IEX HIST end-of-day bars, published the next trading day; never live. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Filings, Form 4 and financials: Source: SEC EDGAR. Earnings dates: Vero’s calendar, marked confirmed or estimated.

Vero is a research tool, not a financial adviser. Nothing on this site is financial advice or a recommendation to buy or sell any security.

Data as of Oct 1, 2026.